132 related articles for article (PubMed ID: 28794318)
1. Dysregulated Expression of MITF in Subsets of Hepatocellular Carcinoma and Cholangiocarcinoma.
Nooron N; Ohba K; Takeda K; Shibahara S; Chiabchalard A
Tohoku J Exp Med; 2017 Aug; 242(4):291-302. PubMed ID: 28794318
[TBL] [Abstract][Full Text] [Related]
2. Induction of MITF expression in human cholangiocarcinoma cells and hepatocellular carcinoma cells by cyclopamine, an inhibitor of the Hedgehog signaling.
Samatiwat P; Takeda K; Satarug S; Ohba K; Kukongviriyapan V; Shibahara S
Biochem Biophys Res Commun; 2016 Jan; 470(1):144-149. PubMed ID: 26773496
[TBL] [Abstract][Full Text] [Related]
3. Hedgehog signalling mediates drug resistance through targeting TAP1 in hepatocellular carcinoma.
Zhou XT; Ding J; Li HY; Zuo JL; Ge SY; Jia HL; Wu J
J Cell Mol Med; 2020 Apr; 24(7):4298-4311. PubMed ID: 32108992
[TBL] [Abstract][Full Text] [Related]
4. Hedgehog Signal Inhibitor GANT61 Inhibits the Malignant Behavior of Undifferentiated Hepatocellular Carcinoma Cells by Targeting Non-Canonical GLI Signaling.
Harada K; Ohashi R; Naito K; Kanki K
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32354204
[TBL] [Abstract][Full Text] [Related]
5. PHF19 activates hedgehog signaling and promotes tumorigenesis in hepatocellular carcinoma.
Xiaoyun S; Yuyuan Z; Jie X; Yingjie N; Qing X; Yuezhen D; Haiguang X
Exp Cell Res; 2021 Sep; 406(1):112690. PubMed ID: 34129846
[TBL] [Abstract][Full Text] [Related]
6. Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity.
Moeini A; Sia D; Zhang Z; Camprecios G; Stueck A; Dong H; Montal R; Torrens L; Martinez-Quetglas I; Fiel MI; Hao K; Villanueva A; Thung SN; Schwartz ME; Llovet JM
J Hepatol; 2017 May; 66(5):952-961. PubMed ID: 28126467
[TBL] [Abstract][Full Text] [Related]
7. PBK/TOPK in the differential diagnosis of cholangiocarcinoma from hepatocellular carcinoma and its involvement in prognosis of human cholangiocarcinoma.
He F; Yan Q; Fan L; Liu Y; Cui J; Wang J; Wang L; Wang Y; Wang Z; Guo Y; Huang G
Hum Pathol; 2010 Mar; 41(3):415-24. PubMed ID: 19954816
[TBL] [Abstract][Full Text] [Related]
8. The transcriptional activity of Gli1 is negatively regulated by AMPK through Hedgehog partial agonism in hepatocellular carcinoma.
Xu Q; Liu X; Zheng X; Yao Y; Wang M; Liu Q
Int J Mol Med; 2014 Sep; 34(3):733-41. PubMed ID: 25017332
[TBL] [Abstract][Full Text] [Related]
9. Differentially expressed gene profiles of intrahepatic cholangiocarcinoma, hepatocellular carcinoma, and combined hepatocellular-cholangiocarcinoma by integrated microarray analysis.
Xue TC; Zhang BH; Ye SL; Ren ZG
Tumour Biol; 2015 Aug; 36(8):5891-9. PubMed ID: 25712376
[TBL] [Abstract][Full Text] [Related]
10. The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma.
Shimizu S; Takehara T; Hikita H; Kodama T; Miyagi T; Hosui A; Tatsumi T; Ishida H; Noda T; Nagano H; Doki Y; Mori M; Hayashi N
J Hepatol; 2010 May; 52(5):698-704. PubMed ID: 20347499
[TBL] [Abstract][Full Text] [Related]
11. Inducible liver-specific overexpression of gankyrin in zebrafish results in spontaneous intrahepatic cholangiocarcinoma and hepatocellular carcinoma formation.
Huang SJ; Cheng CL; Chen JR; Gong HY; Liu W; Wu JL
Biochem Biophys Res Commun; 2017 Aug; 490(3):1052-1058. PubMed ID: 28668389
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of anterior gradient protein 3 in intrahepatic cholangiocarcinoma and hepatocellular carcinoma.
Brychtova V; Zampachova V; Hrstka R; Fabian P; Novak J; Hermanova M; Vojtesek B
Exp Mol Pathol; 2014 Jun; 96(3):375-81. PubMed ID: 24747240
[TBL] [Abstract][Full Text] [Related]
13. Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance.
Karakatsanis A; Papaconstantinou I; Gazouli M; Lyberopoulou A; Polymeneas G; Voros D
Mol Carcinog; 2013 Apr; 52(4):297-303. PubMed ID: 22213236
[TBL] [Abstract][Full Text] [Related]
14. Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.
Nault JC; Couchy G; Balabaud C; Morcrette G; Caruso S; Blanc JF; Bacq Y; Calderaro J; Paradis V; Ramos J; Scoazec JY; Gnemmi V; Sturm N; Guettier C; Fabre M; Savier E; Chiche L; Labrune P; Selves J; Wendum D; Pilati C; Laurent A; De Muret A; Le Bail B; Rebouissou S; Imbeaud S; ; Bioulac-Sage P; Letouzé E; Zucman-Rossi J
Gastroenterology; 2017 Mar; 152(4):880-894.e6. PubMed ID: 27939373
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of gene expression profiles identifies differential biomarkers for hepatocellular carcinoma and cholangiocarcinoma.
Likhitrattanapisal S; Tipanee J; Janvilisri T
Tumour Biol; 2016 Sep; 37(9):12755-12766. PubMed ID: 27448818
[TBL] [Abstract][Full Text] [Related]
16. [Establishment of Cas9 stably expressed human hepatocellular carcinoma and cholangiocarcinoma cell lines].
Zuo CX; Bian XC; Yang ZL; Feng HL; Zhou FY; Liu YQ
Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):572-579. PubMed ID: 30139026
[No Abstract] [Full Text] [Related]
17. High mobility group A1 is expressed in metastatic adenocarcinoma to the liver and intrahepatic cholangiocarcinoma, but not in hepatocellular carcinoma: its potential use in the diagnosis of liver neoplasms.
Abe N; Watanabe T; Izumisato Y; Suzuki Y; Masaki T; Mori T; Sugiyama M; Fusco A; Atomi Y
J Gastroenterol; 2003; 38(12):1144-9. PubMed ID: 14714251
[TBL] [Abstract][Full Text] [Related]
18. Critical role of glioma-associated oncogene homolog 1 in maintaining invasive and mesenchymal-like properties of melanoma cells.
Gunarta IK; Li R; Nakazato R; Suzuki R; Boldbaatar J; Suzuki T; Yoshioka K
Cancer Sci; 2017 Aug; 108(8):1602-1611. PubMed ID: 28635133
[TBL] [Abstract][Full Text] [Related]
19. Differential Expression of Sonic Hedgehog Protein in Human Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
Al-Bahrani R; Nagamori S; Leng R; Petryk A; Sergi C
Pathol Oncol Res; 2015 Sep; 21(4):901-8. PubMed ID: 25740074
[TBL] [Abstract][Full Text] [Related]
20. Mutational landscape of combined hepatocellular carcinoma and cholangiocarcinoma, and its clinicopathological significance.
Sasaki M; Sato Y; Nakanuma Y
Histopathology; 2017 Feb; 70(3):423-434. PubMed ID: 27634656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]